Research and Markets (http://www.researchandmarkets.com/research/k8gvn6/biopharmaceutical) has announced the addition of the "Biopharmaceutical Contract Manufacturing Market, 2015 - 2025" report to their offering.
This report provides an in-depth analysis of the Biopharmaceutical Contract Manufacturing Market for the period of 2015-2025, offering readers a comprehensive understanding of current and future industry challenges, trends and advances. As the biotechnology industry increasingly focuses on maximizing profits, outsourcing has emerged as an ever popular trend for many companies. The report features an extensive review of a diverse group of biopharmaceutical CMOs.
Key Parameters Covered:
- Geographical location
- Scale of operation
- Type of biologics manufactured
- Expression systems
- Types of bioreactors used
-
Fermentation capacity
In addition, it captures some of the potential growth areas which will likely present tremendous opportunities for biopharmaceutical CMOs and ensure an accelerated pace of growth. Some of the niche service areas include manufacturing of ADCs and bispecific antibodies. Specifically, these markets typify huge unmet manufacturing requirements and represent untapped areas of targeted therapy revenue making outsourcing an attractive option.
The base year for the report is 2014; the report provides market forecasts for the period 2015 - 2025. The research, analysis and insights presented in this report is backed by a deep understanding of key insights gathered both from secondary and primary research.
Companies Mentioned - Please click the link below for a full list of all 389 companies mentioned
- 3P Biopharmaceuticals
- AAIPharma Services
- ADC Biotechnology
- ADC Therapeutics
- AERAS
- ARMO Biosciences
- ATMI
- AbbVie
- Ablynx
- Active Biotech
- AdAlta
- Adimab
- Alpax Pharmaceuticals
- Ambrx
- Amega Biotech
-
Amgen
Key Topics Covered:
1. Preface
2. Executive Summary
3. Introduction
4. Biopharmaceutical Contract Manufacturing: Developed Regions
5. Biopharmaceutical Contract Manufacturing: Emerging Regions
6. Competitive Landscape
7. Niche Sectors In Biopharmaceutical Contract Manufacturing
8. Outsourcing Of Biosimilars
9. Recent Developments
10. Market Sizing And Forecast
11. Future Of Biopharmaceutical Cmo Market
12. SWOT Analysis
13. Interview Transcripts
14. Conclusion
15. Appendices
16. List Of Companies
For more information visit http://www.researchandmarkets.com/research/k8gvn6/biopharmaceutical
View source version on businesswire.com: http://www.businesswire.com/news/home/20151125005725/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biopharmaceuticals
